NEW YORK (360Dx) – Three years after its founding and with a new name in tow, Nightingale Health is poised to move into the clinical market with technology that it said can provide information on 220 metabolic biomarkers for chronic diseases.
NEW YORK (360Dx) – Three years after its founding and with a new name in tow, Nightingale Health is poised to move into the clinical market with technology that it said can provide information on 220 metabolic biomarkers for chronic diseases.
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.